Brigatinib US FDA Label
- Compound: 5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine
- Description: Brigatinib is an organic molecular entity. It has a role as an antineoplastic agent and a tyrosine kinase inhibitor.
- Brand Name:
- Code(s): AP 26113
- Approved:
- Kinase Class: RY
- Inhibitor Type: I ½B
- Literature (PubMed): 0
- Target(s): ALK receptor tyrosine kinase , epidermal growth factor receptor , fms related receptor tyrosine kinase 3 , insulin like growth factor 1 receptor , ROS proto-oncogene 1, receptor tyrosine kinase
- Disease(s): non-small-cell lung carcinoma